Organon & Co. (OGN) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$13.31
Price Target
$11.33
Target Range
$8.00 — $14.00
Analyst Rating
Hold
Forward P/E3.9x
Trailing P/E18.5x
Forward PEG—
Implied Growth+380.5%
Median Target$12.00
Analyst Spread53.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$8
-39.9%
Consensus
$11
-14.9%
Bull Case
$14
+5.1%
Valuation Model TargetsConfidence: 34/100
Bear$30
Base$30
Bull$126
OGN Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Organon & Co. (OGN) has a Wall Street consensus price target of $11.33, based on estimates from 9 covering analysts. With the stock currently trading at $13.31, this represents a potential downside of -14.9%. The company has a market capitalization of $3.46B.
Analyst price targets range from a low of $8.00 to a high of $14.00, representing a 53% spread in expectations. The median target of $12.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 3 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, OGN trades at a trailing P/E of 18.5x and forward P/E of 3.9x. Analysts expect EPS to grow +380.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $30.07, with bear and bull scenarios of $29.50 and $125.70 respectively. Model confidence stands at 34/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+24.7%
Avg Forward P/E13.2x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 PFEPfizer Inc. | $150.6B | $26.48 | $27.27 | +3.0% | Hold | 8.9x | 39 |
 VTRSViatris Inc. | $20.2B | $17.39 | $15.25 | -12.3% | Hold | 7.1x | 12 |
 ABBVAbbVie Inc. | $358.4B | $202.64 | $256.64 | +26.6% | Buy | 14.3x | 41 |
 HLNHaleon plc | $41.4B | $9.31 | $10.20 | +9.6% | Buy | 22.2x | 4 |
 TEVATeva Pharmaceutical Industries Limited | $41.9B | $36.01 | $39.00 | +8.3% | Buy | 14.5x | 46 |
 PRGOPerrigo Company plc | $1.6B | $11.72 | $20.00 | +70.6% | Hold | 5.6x | 36 |
 EVAXEvaxion Biotech A/S | $26M | $4.07 | — | — | — | — | — |
 ANIPANI Pharmaceuticals, Inc. | $1.8B | $83.91 | $124.00 | +47.8% | Buy | 9.2x | 10 |
 MCKMcKesson Corporation | $92.1B | $752.30 | $1006.50 | +33.8% | Buy | 19.3x | 31 |
 CAHCardinal Health, Inc. | $43.6B | $185.22 | $249.67 | +34.8% | Buy | 17.9x | 33 |
Upside Potential Comparison
PRGOANIPCAHMCKABBVHLNTEVAPFESee OGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOGN — Frequently Asked Questions
Quick answers to the most common questions about buying OGN stock.
What is the OGN stock price target for 2026?
OGN's consensus price target is $11.33, -14.9% below the current price of $13.315. The 9 analysts tracking OGN see downside risk at present valuations.
Is OGN a buy, sell, or hold?
OGN has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is leaning bearish, with 3 Sell/Strong Sell ratings. The consensus 12-month price target of $11.33 implies -14.9% downside from current levels.
Is OGN stock overvalued or undervalued?
With a forward P/E of 3.8555x, OGN trades at a relatively low valuation. The consensus target of $11.33 implies -14.9% move, suggesting the market may be pricing in risks.
How high can OGN stock go?
The most bullish Wall Street analyst has a price target of $14 for OGN, while the most conservative target is $8. The consensus of $11.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $126 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover OGN stock?
OGN is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 4 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the OGN stock forecast?
The 12-month OGN stock forecast based on 9 Wall Street analysts shows a consensus price target of $11.33, with estimates ranging from $8 (bear case) to $14 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $30, with bear/bull scenarios of $30/$126.
What is OGN's fair value based on fundamentals?
Our quantitative valuation model calculates OGN's fair value at $30 (base case), with a bear case of $30 and bull case of $126. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 34/100.
What is OGN's forward P/E ratio?
OGN trades at a forward P/E ratio of 3.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy OGN stock?
Analysts are cautious on OGN, with 3 Sell ratings and a price target of $11.33 (-14.9% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do OGN price targets vary so much?
OGN analyst price targets range from $8 to $14, a 53% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $11.33 consensus represents the middle ground. Our model's $30-$126 range provides an independent fundamental perspective.